MY01
MY01 is a medical device company that develops FDA-cleared MEMS-based continuous intracompartmental pressure monitors for acute compartment syndrome diagnosis. Its CPST platform serves hospital trauma centers, orthopedic surgeons, and military medical units across North America, UK, and EU markets.
- Company typePrivate
- Founded2015
- HeadquartersMontréal, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MY01 does
MY01 is a Montreal-based medical device company founded in 2015 as a spin-off from McGill University (via parent company Nxtsens Microsystems) that develops FDA-cleared continuous intracompartmental pressure monitors for the diagnosis of acute compartment syndrome. Its core technology is the Continuous Perfusion Sensing Technology (CPST) platform, which uses Micro-Electro-Mechanical Systems (MEMS) sensors to provide real-time, continuous digital pressure readings of limb compartments — a capability demonstrated in published clinical evidence to be 600% more accurate than competing devices (Synthes, STIC) and to enable diagnosis approximately 4 hours earlier than traditional methods. The product ecosystem comprises the MY01 Continuous Compartmental Pressure Monitor hardware, a Bluetooth-enabled mobile application with FDA-cleared perfusion pressure calculation, a hospital-grade base station, and a SOC 2 Type II compliant cloud-based monitoring platform.
The company serves hospital trauma centers, orthopedic surgeons, emergency physicians, and U.S. military medical units across the United States, Canada, the United Kingdom, and the European Union. MY01 operates a primarily enterprise field sales go-to-market supplemented by channel partnerships (national US distributor network, LEDA Orthopedics in the UK, Optimal Healthcare Advisors for trauma center outcomes), with direct sales leadership including a US Director of Sales and a Chief Commercial Officer. Revenue is generated through hardware device sales bundled with cloud platform access, with reimbursement economics anchored by Medicare NTAP (up to $2,112.50 per inpatient case), TPT for outpatient settings through 2028, and CPT code 20950.
MY01 has shipped 2,000+ devices and documented 1,000+ clinical cases as of late 2024, with a team of 50 employees from 20 countries. Total disclosed funding is approximately $16 million across a $12.5M Series A led by Investissement Québec (April 2023), a $2.5M BioMed Propulsion grant (September 2024), $1.15M CAD from Canada Economic Development (August 2024), and a strategic investment by Joe Kiani, founder of Masimo, who joined the board in September 2025.
MY01 firmographics
Firmographics- Name
- MY01
- Legal name
- MY01 Inc.
- Website
- https://my01.io
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MY01 is a medical device company that develops FDA-cleared MEMS-based continuous intracompartmental pressure monitors for acute compartment syndrome diagnosis. Its CPST platform serves hospital trauma centers, orthopedic surgeons, and military medical units across North America, UK, and EU markets.
- Ownership category
- akta.pro rank
MY01 industry classification
Industry- Product category
- Compartment Pressure Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Pressure & Force Sensors (Pressure/Strain/Load Cells) (HDAHALAB), Sensors, MEMS & Imaging ICs (HDAHAAAG)
Keywords
Where MY01 is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
MY01 business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Continuous Compartment Pressure Monitor Device Sales: Sale of the FDA-cleared MY01 Continuous Compartmental Pressure Monitor device to hospitals and trauma centers. The device is a hardware product with no consumables required, making it suitable for trauma settings.
- Cloud-Based Monitoring Platform: Cloud-based pressure monitoring platform accessible to healthcare providers for patient care, research, and education. Part of the overall service offering bundled with device.
- Medicare NTAP and TPT Reimbursement: Medicare reimbursement through NTAP (New Technology Add-on Payment) for inpatient and TPT (Transitional Pass-Through) for outpatient settings. NTAP provides up to $2,112.50 additional payment per case.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Per procedure | Medicare NTAP Reimbursement - Inpatient |
| Transaction based/ take rate | Per procedure | Medicare TPT Reimbursement - Outpatient |
| Unit Pricing | Per procedure | CPT Code 20950 - Monitoring of interstitial fluid pressure |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
MY01 product offering
Product offeringCore offering
MY01 develops, manufactures, and sells the FDA-cleared MY01 Continuous Compartmental Pressure Monitor—an all-in-one, consumable-free hardware device that uses MEMS-based sensors to deliver continuous, real-time intracompartmental pressure readings, paired with a Bluetooth-connected mobile application and cloud-based Continuous Perfusion Sensing Technology (CPST) platform for hospitals, trauma centers, and orthopedic surgeons diagnosing acute compartment syndrome.
Product overview
MY01 offers a unified medical device ecosystem centered on the Continuous Compartmental Pressure Monitor and its companion Mobile Application, both FDA-cleared. The system is built on the Continuous Perfusion Sensing Technology (CPST) Platform, which integrates real-time intracompartmental pressure monitoring with perfusion pressure calculations. The MY01 Base Station provides infrastructure support for hospital settings. Together, these products enable continuous monitoring that can detect compartment syndrome 4 hours earlier than traditional methods.
Differentiator
Problem solved
Functional benefit
Brands
- Continuous Perfusion Sensing Technology (CPST): MY01's proprietary platform providing real-time, objective continuous perfusion pressure data for bedside patient monitoring
Products and services
- MY01 Continuous Compartmental Pressure Monitor FDA-cleared, all-in-one, consumable-free hardware device that uses MEMS sensor technology to provide continuous intracompartmental pressure monitoring, enabling earlier diagnosis of acute compartment syndrome in trauma patients at hospital trauma centers.
- MY01 Mobile Application Bluetooth-enabled iOS and Android mobile application that connects to the MY01 monitor and displays real-time pressure data, trend information, and perfusion pressure calculations with patient-specific diastolic blood pressure inputs for healthcare providers.
- MY01 Base Station Charging station and connectivity hub for the MY01 Continuous Compartmental Pressure Monitor, available with a mobile device cart and companion tablet option for hospital and clinical use.
- Continuous Perfusion Sensing Technology (CPST) Platform Integrated bedside patient monitoring platform that combines the MY01 hardware monitor and mobile application into a unified solution, delivering real-time, objective continuous perfusion pressure data with cloud connectivity, trend analytics, and clinical decision support for healthcare providers.
Quantifiable outcome
- 4 hours earlier diagnosis compared to traditional methods
- +5 more outcomes
Companies that use MY01
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
MY01 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
MY01 partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- U.S. Army (Defense Logistics Agency)coreOfficial contributor to 2026 Best Medic Competition at Joint Base San Antonio-Camp Bullis. Received National Stock Number (NSN) for flagship Pressure Monitor enabling military medical unit procurement.
- Optimal Healthcare AdvisorscorePartnership to help trauma centers transform real-time data into measurable outcomes. OHA provides expertise in care quality improvement, documentation streamlining, and outcomes measurement for trauma centers implementing MY01 technology.
- U.S. Distributor NetworkcoreNew distribution partnerships expanding MY01's national presence across the United States, strengthening mission to improve patient outcomes and enable trauma centers with actionable insights.
- C100minorSelected for C100 Growth Program providing access to Canadian tech executives, venture capital networks, and Silicon Valley expertise for accelerated growth.
- LEDA OrthopedicscoreUK distribution partnership making MY01's continuous compartment pressure monitoring technology available to surgeons and patients throughout the United Kingdom. LEDA Orthopedics serves as the exclusive distribution partner for UK market expansion.
- Nxtsens MicrosystemscoreParent company and engineering partner. Nxtsens developed and manufactures the MEMS sensor technology. MY01 spun off from Nxtsens which originated as McGill University Master's project. Nxtsens won 2nd place at McGill Dobson Cup in 2016.
Scale indicators8 records
Recent moves7 records
Expansion highlights7 records
MY01 competitors and assessment
Company assessmentDirect peers
- Stryker: One of the largest orthopedic medical device companies in the world. Stryker acquired C2Dx and offers STIC compartment pressure monitoring products that compete directly with MY01 in trauma centers, and brings an enormous orthopedic sales force and bundled contracting leverage.
- Raumedic AG: German medical device specialist focused on pressure measurement and tubing systems, including compartment pressure monitoring solutions used in orthopedic trauma. Directly comparable product offering and clinical application to MY01's continuous pressure monitor.
Broad incumbents
- Masimo: Global leader in noninvasive patient monitoring technologies (pulse oximetry, rainbow sensors). Joe Kiani, Masimo's founder, is on MY01's board. Comparable as a connected clinical-grade vital signs monitoring company and natural strategic acquirer or platform partner.
- ICU Medical: Medical device company focused on IV therapy, infusion pumps, and connected patient monitoring. Comparable business model combining hardware devices with software/connectivity, and operates in similar hospital procurement channels.
- Baxter International: Global medical device and pharmaceutical company with a strong portfolio in infusion systems, patient monitoring, and surgical solutions. Comparable hospital-customer base and complementary pressure/fluid monitoring portfolio.
- Medtronic: One of the world's largest medical device companies with extensive patient monitoring, orthopedic, and connected care offerings. Comparable as a broad incumbent in hospital-based continuous monitoring and orthopedic trauma markets.
- Royal Philips: Global health technology company with a major patient monitoring and connected care division serving hospitals worldwide. Comparable as a connected bedside monitoring platform incumbent that could compete with or acquire MY01's CPST platform.
- GE HealthCare: Major medical equipment and patient monitoring company offering continuous vital signs monitoring systems to hospitals globally. Comparable as a broad incumbent in clinical-grade bedside monitoring with overlapping hospital customer base.
- Smith+Nephew: Global medical device company with a significant orthopedic trauma and sports medicine franchise. Comparable orthopedic trauma customer base and hospital sales channels that overlap with MY01's target buyer profile.
- Zimmer Biomet: Leading orthopedic medical device company with deep trauma center relationships and a broad orthopedic surgical portfolio. Comparable hospital customer base in orthopedic trauma where MY01's compartment pressure monitor is used.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
MY01 social profiles
Digital presenceMY01 compliance and trust
Trust signalCompliance2 records
MY01 financial estimates
Financial estimateRevenue estimate
Valuation estimate
MY01 leadership team
Management profileNumber of profiles
Profiles9 records
MY01 funding detail
Funding detailFunding overview
Funding rounds4 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MY01 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MY01
What does MY01 do?
MY01 develops, manufactures, and sells the FDA-cleared MY01 Continuous Compartmental Pressure Monitor—an all-in-one, consumable-free hardware device that uses MEMS-based sensors to deliver continuous, real-time intracompartmental pressure readings, paired with a Bluetooth-connected mobile application and cloud-based Continuous Perfusion Sensing Technology (CPST) platform for hospitals, trauma centers, and orthopedic surgeons diagnosing acute compartment syndrome.
Is MY01 a public or private company?
MY01 is a private company. It is classified as venture growth investor backed and is currently operating.
When was MY01 founded?
MY01 was founded in 2015. It employs 11 to 50 people.
Where is MY01 based?
MY01 is headquartered in Montréal, Canada, in the North America region.
How does MY01 make money?
Three revenue lines are on record. Continuous Compartment Pressure Monitor Device Sales are the primary driver. The others are cloud-Based Monitoring Platform and medicare NTAP and TPT Reimbursement.
Who are MY01's main competitors?
Direct peers on record are Stryker and Raumedic AG. Broad incumbents are Masimo, ICU Medical, Baxter International, Medtronic, Royal Philips, GE HealthCare, Smith+Nephew and Zimmer Biomet.
Does MY01 have an API?
No public API is recorded for MY01.
What industry is MY01 in?
MY01's product category is Compartment Pressure Monitoring Devices. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.